Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Atrium Therapeutics, Inc.NASDAQ: RNA
Other Working Capital · Q1 FY2026 · quarter ended Mar 2026
Other working capital of -$9.12M in Q1 FY2026
Q1 FY2026 other working capital was -$9.12M.
Context
- Other working capital amounted to 21.1% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- (3.93M) USD
- Year-over-year change
- —
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.93M) | — |
Other Working Capital vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Other Working Capital figures are available to compare.
Cash Flow Statement
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.